Scarica l'app Stockscreener
42.95
1.13%
-0.49
Pre-mercato:
42.80
-0.15
-0.35%
Precedente Chiudi:
$43.44
Aprire:
$43.52
Volume 24 ore:
428.34K
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.80B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-9.2565
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
-0.07%
1M Prestazione:
-15.62%
6M Prestazione:
-18.11%
1 anno Prestazione:
+23.63%
Intervallo 1D:
$42.04
$43.52
Intervallo di 1 settimana:
$41.01
$43.99
Portata 52W:
$20.08
$57.28
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Nome
Tarsus Pharmaceuticals Inc
Settore
Industria
Telefono
(949) 409-9820
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Confronta TARS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
42.95 | 1.81B | 17.39M | -135.89M | -123.00M | -4.64 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-20 | Iniziato | Goldman | Neutral |
| 2023-07-18 | Iniziato | William Blair | Outperform |
| 2023-05-18 | Iniziato | Guggenheim | Buy |
| 2022-08-01 | Iniziato | Barclays | Overweight |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-23 | Iniziato | Oppenheimer | Outperform |
| 2020-11-10 | Iniziato | BofA Securities | Buy |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-11-10 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
What is HC Wainwright’s Estimate for TARS Q2 Earnings? - Defense World
Nuveen Asset Management LLC Sells 15,186 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus to Participate in Upcoming Investor Conferences | TARS Stock News - GuruFocus
Tarsus Lines Up Triple Conference Appearances: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Ameriprise Financial Inc. - Defense World
BNP Paribas Financial Markets Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Upgraded by HC Wainwright - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by HC Wainwright - Defense World
TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | - GuruFocus
Tarsus Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | TARS Stock News - GuruFocus
TARS: H.C. Wainwright Initiates Coverage with a Buy Rating | TARS Stock News - GuruFocus
Tarsus Pharmaceuticals Advances Novel Treatments for Eye and Vector-Borne Diseases - utahdailynewswire.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.16 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Bank of America Corp DE - Defense World
Tarsus Pharmaceuticals at H.C. Wainwright: Expanding Horizons with Xdemvy By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals Shows Rising Price Performance With Jump To 84 RS Rating - inkl
When the Price of (TARS) Talks, People Listen - news.stocktradersdaily.com
Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Tarsus Pharmaceuticals Inc Enters Oversold Territory (TARS) - Nasdaq
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Northern Trust Corp - Defense World
Transcript : Tarsus Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com
Tarsus Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for TARS - Nasdaq
Tarsus Pharmaceuticals (TARS) Expected to Announce Earnings on Wednesday - Defense World
Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus to Participate in Upcoming Investor Conferences | TARS St - GuruFocus
Dimensional Fund Advisors LP Sells 62,658 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals Reports First Quarter 2025 Sales Growth - VisionMonday.com
Tarsus Pharmaceuticals anticipates 85,000-90,000 XDEMVY bottles dispensed in Q2 2025 amid expanded DTC campaign - MSN
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $51.00 at The Goldman Sachs Group - Defense World
TARS: Goldman Sachs Updates Price Target for Tarsus Pharmaceuticals | TARS Stock News - GuruFocus
Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance
6 Analysts Assess Tarsus Pharmaceuticals: What You Need To Know - Benzinga
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal - Benzinga
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown - Quantisnow
Raymond James Financial Inc. Acquires Shares of 19,999 Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $84.00 - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Down – What’s Next? - Defense World
How to Take Advantage of moves in (TARS) - news.stocktradersdaily.com
Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts - Yahoo Finance
Envestnet Asset Management Inc. Sells 2,282 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals Insiders Sold US$3.9m Of Shares Suggesting Hesitancy - simplywall.st
Decoding Tarsus Pharmaceuticals Inc (TARS): A Strategic SWOT Ins - GuruFocus
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tarsus Pharmaceuticals’ Earnings Call Highlights Robust Growth - TipRanks
TARS: Guggenheim Raises Price Target for Tarsus Pharmaceuticals - GuruFocus
TARS: Guggenheim Raises Price Target for Tarsus Pharmaceuticals | TARS Stock News - GuruFocus
TARS: Guggenheim Boosts Price Target After Q1 Update | TARS Stoc - GuruFocus
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):